Alnylam Pharmaceuticals, Inc. (ALNY) vs BioNTech SE Sponsored ADR (BNTX)

Alnylam Pharmaceuticals, Inc. and BioNTech SE Sponsored ADR are both Biotechnology companies. Alnylam Pharmaceuticals, Inc. is the larger, with a market value of $31.2B against $24.9B — 1.2× the size. BioNTech SE Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Alnylam Pharmaceuticals, Inc. trades at 43.6×. Alnylam Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 95.1% against −3.33%. Alnylam Pharmaceuticals, Inc. has the higher net margin (16.1% vs −65.8%) and the higher return on invested capital (0.00% vs −38.4%). Both pay a dividend; Alnylam Pharmaceuticals, Inc. yields more (2.52% vs 1.33%). Across the 20 metrics below, Alnylam Pharmaceuticals, Inc. leads on 16 and BioNTech SE Sponsored ADR on 4.